Abivax (ABVX) Stock Chart & Stock Price History $69.86 -2.05 (-2.86%) Closing price 08/13/2025 03:59 PM EasternExtended Trading$69.91 +0.05 (+0.07%) As of 08/13/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Abivax Stock Price Performance The Abivax (ABVX) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 535.63%, with a year-to-date return of 854.32%. In the past month, the stock has increased 691.12%, reflecting recent market activity. As of the latest close, Abivax traded at $69.86 with a market cap of $5.28 billion and volume of 1.42 million shares. Receive ABVX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Abivax and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.39%1 Month Performance+691.12%3 Month Performance+1,045.18%Year-To-Date Performance+854.32%1 Year Performance+535.63% ABVX Stock Chart for Thursday, August, 14, 2025 ABVX Chart by TradingView Abivax Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/13/2025$71.91$69.86-2.86%$73.90$68.751.42 million shs$5.28 billion08/12/2025$69.00$71.91+4.22%$72.26$69.10959,886 shs$5.43 billion08/11/2025$70.13$69.00-1.61%$70.92$68.54583,945 shs$4.38 billion08/08/2025$70.02$70.13+0.16%$72.98$68.50667,272 shs$4.45 billion08/07/2025$69.09$70.02+1.35%$71.67$69.071.15 million shs$4.44 billion08/06/2025$70.91$69.09-2.57%$72.69$67.091.64 million shs$4.39 billion08/05/2025$72.07$70.91-1.61%$72.14$68.59926,152 shs$4.50 billion08/04/2025$71.94$72.07+0.18%$72.55$69.64526,469 shs$4.57 billion08/01/2025$71.77$71.94+0.24%$72.95$69.371.25 million shs$4.57 billion07/31/2025$70.83$71.77+1.33%$75.51$69.671.46 million shs$4.56 billion Get the Latest News and Ratings for ABVX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Abivax and its competitors with MarketBeat's FREE daily newsletter. 07/30/2025$69.80$70.83+1.48%$71.84$69.581.36 million shs$4.50 billion07/29/2025$66.57$69.80+4.85%$70.92$66.112.34 million shs$4.43 billion07/28/2025$66.49$66.57+0.12%$68.12$65.671.72 million shs$4.23 billion07/25/2025$69.76$66.49-4.69%$70.25$65.873.54 million shs$4.22 billion07/24/2025$68.60$69.76+1.69%$72.90$67.338.33 million shs$4.43 billion07/23/2025$10.00$68.60+586.00%$71.35$62.5027.78 million shs$4.35 billion07/22/2025$10.14$10.00-1.38%$10.73$9.96954,676 shs$634.70 million07/21/2025$9.95$10.14+1.91%$10.64$10.051.48 million shs$643.59 million07/18/2025$10.34$9.95-3.77%$10.32$9.86619,718 shs$631.53 million07/17/2025$9.88$10.34+4.66%$10.46$9.79798,395 shs$656.30 million07/16/2025$8.85$9.88+11.64%$10.26$9.252.32 million shs$627.08 million07/15/2025$8.83$8.85+0.23%$9.32$8.85738,159 shs$561.71 million07/14/2025$8.27$8.83+6.77%$8.92$8.11805,005 shs$560.44 million Related Companies TEVA Stock Chart GMAB Stock Chart RDY Stock Chart QGEN Stock Chart MRNA Stock Chart ASND Stock Chart VTRS Stock Chart BBIO Stock Chart VRNA Stock Chart BPMC Stock Chart Receive ABVX Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Abivax and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ABVX) was last updated on 8/14/2025 by MarketBeat.com Staff From Our PartnersHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhen the levee breaksThe U.S. Treasury just confirmed it plans to borrow $1.01 trillion this quarter—nearly double what was project...Porter & Company | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredD.C.’s secret plan to crush the debt.At a recent gathering with some of the most powerful people in America, Jeff discovered the Trump administrati...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Abivax SA Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Abivax With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access